| Entry |
|
|---|
| Name |
Telotristat ethyl (USAN);
Xermelo (TN)
|
|---|
| Product |
|
|---|
| Formula |
C27H26ClF3N6O3
|
|---|
| Exact mass |
574.1707
|
|---|
| Mol weight |
574.982
|
|---|
| Structure |
|
|---|
| Simcomp |
|
|---|
| Remark |
| Product (DG02809): | D09974<US> |
|
|---|
| Efficacy |
Antidiarrheal, Tryptophan hydroxylase inhibitor |
|---|
| Disease |
Carcinoid syndrome [DS: H00034] |
|---|
| Comment |
Treatment of carcinoid syndrome diarrhea
|
|---|
| Target |
|
|---|
| Pathway |
|
|---|
| Brite |
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
A ALIMENTARY TRACT AND METABOLISM
A16 OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS
A16A OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS
A16AX Various alimentary tract and metabolism products
A16AX15 Telotristat
D09974 Telotristat ethyl (USAN) <US>
USP drug classification [BR:br08302]
Gastrointestinal Agents
Anti-Diarrheal Agents
Telotristat
D09974 Telotristat ethyl (USAN)
Target-based classification of drugs [BR:br08310]
Enzymes
Oxidoreductases (EC1)
Other monooxygenases
TPH
D09974 Telotristat ethyl (USAN) <US>
New drug approvals in the USA [br08319.html]
New molecular entities and new therapeutic biological products
D09974
New drug approvals in Europe [br08329.html]
European public assessment reports (EPAR) authorised medicine
D09974
New drug approvals in the USA, Europe and Japan [br08328.html]
Approval dates by FDA, EMA and PMDA
D09974
|
|---|
| Other DBs |
|
|---|
| LinkDB |
|
|---|
| KCF data |
ATOM 40
1 C8y C 22.2600 -25.9000
2 C8x C 22.2600 -27.3000
3 C8x C 23.4500 -28.0000
4 C8y C 24.7100 -27.3000
5 C8y C 24.7100 -25.9000
6 C8x C 23.4500 -25.2000
7 C1c C 25.9000 -28.0000
8 O2a O 27.0900 -27.3000
9 C8y C 28.2800 -28.0000
10 C1d C 25.9000 -29.4700
11 X F 24.7100 -30.1700
12 X F 27.0900 -30.1700
13 X F 25.9000 -30.8700
14 N5x N 28.2800 -29.4700
15 C8y C 29.5400 -30.1700
16 N5x N 30.8000 -29.4700
17 C8y C 30.8000 -28.0000
18 C8x C 29.5400 -27.3000
19 C8y C 31.9900 -27.3000
20 C8x C 33.1800 -28.0000
21 C8x C 34.4400 -27.3000
22 C8y C 34.4400 -25.9000
23 C8x C 33.2500 -25.2000
24 C8x C 31.9900 -25.9000
25 C1b C 35.6300 -25.2000
26 C1c C 36.8200 -25.9000
27 C7a C 38.0100 -25.2000
28 O7a O 39.2000 -25.9000
29 O6a O 38.0100 -23.8000
30 N1a N 36.8200 -27.3000
31 N4y N 25.9000 -25.2000
32 C8x C 25.9000 -23.8000
33 N5x N 27.2300 -25.6200
34 C8y C 28.0700 -24.5000
35 C8x C 27.2300 -23.3800
36 C1a C 29.4700 -24.5000
37 X Cl 21.0700 -25.2000
38 N1a N 29.5400 -31.5700
39 C1b C 40.4181 -25.2099
40 C1a C 41.5995 -25.9050
BOND 43
1 1 2 2
2 2 3 1
3 3 4 2
4 4 5 1
5 5 6 2
6 1 6 1
7 4 7 1
8 7 8 1
9 8 9 1
10 7 10 1 #Up
11 10 11 1
12 10 12 1
13 10 13 1
14 9 14 2
15 14 15 1
16 15 16 2
17 16 17 1
18 17 18 2
19 9 18 1
20 17 19 1
21 19 20 1
22 20 21 2
23 21 22 1
24 22 23 2
25 23 24 1
26 19 24 2
27 22 25 1
28 25 26 1
29 26 27 1
30 27 28 1
31 27 29 2
32 26 30 1 #Up
33 5 31 1
34 32 31 1
35 31 33 1
36 33 34 2
37 34 35 1
38 32 35 2
39 34 36 1
40 1 37 1
41 15 38 1
42 28 39 1
43 39 40 1
|
|---|
